Anne Milgram

DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process

DEA Warns Of Crackdown On Ketamine Prescribing Following Matthew Perry's Death

Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In 'Soon-To-Be President Harris'

DEA Warns Of Crackdown On Ketamine Prescribing Following Matthew Perry's Death

Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In 'Soon-To-Be President Harris'

DEA Delays Cannabis Rescheduling Decision Until After November Presidential Election

Senators Booker, Schumer, Wyden And Four More Dems Urge DOJ, DEA To Reschedule Marijuana

DEA Delays Cannabis Rescheduling Decision Until After November Presidential Election

Senators Booker, Schumer, Wyden And Four More Dems Urge DOJ, DEA To Reschedule Marijuana

'Opaque Political Processes,' DEA Rescheduling Deadline, And Now A New Presidential Candidate, It's No Wonder Cannabis Stocks Are Over The Place

Kentucky Gov Andy Beshear To DEA: Reschedule Cannabis 'Marijuana Products Will Reduce Suffering'

Anne Milgram Recent News

Supreme Court Ruling Will Help This Company's Battle Against DEA's 'Kangaroo Court' And Anti-Cannabis Research Policy

GOP Congress Members To DEA Chief Milgram: Why Haven't You Signed Cannabis Rescheduling Proposal?

Reps. Clyde and Cline demand answers from DEA administrator Milgram on her refusal to sign cannabis rescheduling proposal, breaking decades of precedent.

DEA Vs. Dept Of Justice Over Cannabis Rescheduling: Too Many Cooks In The Kitchen?

Current and former DEA agents say they need 'more time' and scientific evidence. But the HHS recommended reclassifying cannabis in 2023.

DEA And Cannabis Rescheduling: A Rollercoaster Ride You Don't Want To Miss, But Keep Your Seatbelts On

DEA's decision not to sign the rescheduling order caused a roller coaster ride for the cannabis industry, with more confusion ahead.

Justin Trudeau Says There Are No Downsides To Cannabis Legalization, Slams International Treaties' Excuse To Reject Reform

DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'

The DEA's silence beyond acknowledging the receipt of the U.S. Department of Health and Human Services (HHS) suggestion to reclassify marijuana has been a source of frustration for advocates and legislators, including co-chairs of the Congressional Cannabis Caucus Rep. Barbara Lee (D-CA) and Rep. Earl Blumenauer, (D-OR) who have complained about the DEA's lack of transparency.

Biden Continues To Block Weed Sales In DC After Touting Marijuana Rescheduling And Pardons In SOTU

Washington, D.C. won't be able to legalize recreational cannabis sales as part of the budget proposal for Fiscal Year 2025 that the Biden-Harris administration submitted to Congress on Monday. The D.C. cannabis provision has been blocking the nation's capital from using its local tax dollars to implement a legal recreational cannabis sales program, even though DC voters overwhelmingly approved cannabis legalization in 2014. President Joe Biden decided once again to exclude Washington, D.C. from legalizing recreational cannabis sales as part of the Fiscal Year 2025 budget request on the heels of last week's State of the Union speech, during which he reiterated his stance that no one should be incarcerated for possessing cannabis. Moreover, the Department of Health and Human Services, under Biden's direction, recommended moving marijuana from Schedule I to a Schedule III substance under the Controlled Substances Act, on Aug, 29 in a letter to Drug Enforcement Agency (DEA) administrator Anne Milgram.

Weed Could Be Biden's Ace Up The Sleeve Against Trump If He Would Fulfill His Campaign Promises

With the 2024 presidential general election this year, Americans seem to be up for a presidential rematch. In his analysis of recent polls, CNN's Harry Enten said surveys from The New York Times/Siena College, CBS News/YouGov, Fox News and The Wall Street Journal all gave Donald Trump "a higher percentage of the vote than Biden by margins ranging from 2 to 4 points." To address the erosion in support among voters, President Joe Biden has been working on engaging with younger voters. He recently made his debut on the popular social media platform TikTok. The move, coincided with the Super Bowl, signaled a potential strategic shift in Biden's re-election campaign. Moreover, in September, the White House addressed young people via a fact sheet that listed issues that the fastest-growing demographic in the country is facing - from student debt and gun violence to environmental concerns to the approach to cannabis reform. The introduction to the "Addressing a Failed Approach to Marijuana" section of the fact sheet highlighted all the wrongs criminalization of marijuana possession has brought upon as well as Biden's 2022 pardon of federal cannabis prisoners, which impacted some 6,500 individuals with prior convictions for simple weed possession.

Congresswoman To DEA: 'Reject Any Argument' That Marijuana Rescheduling Violates US Treaty Obligations

Rep. Sydney Kamlager-Dove emphasizes the critical need for transparency in the DEA's discussions surrounding global drug policy agreements.

Congressman Presses DEA For Action On Cannabis Scheduling Review, Calls Current Situation 'Arcane And Out-Of-Touch'

Rep Blumenauer sent another letter to the DEA's Anne Milgram, pushing for more transparency and action on cannabis reform. He urges 'full descheduling' of cannabis and for the DEA to prioritize public safety rather than criminalization.

GOP Congressman Says 'FDA Ignored Marijuana's Risks' In Rescheduling Proposal, Argues Agency's Credibility 'Challenged By COVID'

DEA Under Pressure To 'Deschedule Marijuana Altogether': 12 US Senators Send Demand To Merrick Garland, Anne Milgram

John Fetterman and Elizabeth Warren are among the 12 Democratic senators who urge the U.S. Attorney General and the Drug Enforcement Administration (DEA) to legalize cannabis fully.

Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry

Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about potential regulatory changes that could benefit the cannabis industry after the US government released 252 pages of documents confirming the HHS's recommendation that the DEA reschedule cannabis as Schedule III under the Controlled Substances Act. The documents state that cannabis has a currently accepted medical use in treatment and potential for abuse less than drugs in Schedules I and II. In August, the Assistant Secretary for Health wrote a letter to the DEA calling for marijuana to be reclassified. The Secretary of HHS has confirmed that his department shared a comprehensive scientific review with the DEA in response to President Joe Biden's scheduling directive.

12 State Attorneys General To DEA: Reschedule Marijuana To 'Defend Public Safety,' Cannabis Stocks Jump

In a major development in the ongoing debate over marijuana policy, 12 Democratic state attorneys general have formally requested the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III of the Controlled Substances Act.

Congressman Presses DEA On Marijuana Rescheduling Review: 'Move As Swiftly As Possible'

U.S. Rep Steve Cohen (D-TN) has fired a shot across the bow of the Drug Enforcement Administration (DEA), demanding swift action on the ongoing review of marijuana's federal classification.

DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes

The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024.

Marijuana Legalization: 31 Bipartisan House Reps Urge DEA To Reassess Cannabis Scheduling

A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state marijuana legalization efforts as it carries out its review into

DEA Vs. HHS Over Marijuana Rescheduling: Former Gov Officials Say It Would 'Supersize' The Industry

Former DEA chiefs and retired White House drug czars are expressing concerns over the possible rescheduling of cannabis.

Attorney Sues HHS For Copy Of Biden's Letter Requesting Cannabis Scheduling Review, Does It Exist?

Attorney Matthew C. Zorn filed a complaint Friday in the U.S. District Court in Washington, D.C. against the Dept of Health and Human Services (HHS) demanding that it produce a requested copy of the letter issuing the cannabis scheduling review directive.

Republicans Present Bill Blocking Cannabis Legalization Without Congressional Approval

Senator Cynthia Lummis (R) and her colleague Senator Steve Daines (R), presented a bill to block cannabis legalization without congressional approval.

Chuck Schumer Responds To Cannabis Rescheduling, Sen. Ron Wyden Calls It 'Historic Leap'

New York Senator Chuck Schumer (D) responded to Wednesday's news that the Dept. of Health and Human Services wrote to DEA administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.

Health Officials To DEA: Ease Federal Restrictions On Cannabis - Will This Set Stage For Legalization?

A top official at the Department of Health and Human Services wrote to Drug Enforcement Agency administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act, according to a letter dated Aug. 29 seen by Bloomberg News.

Matt Gaetz Pushes DEA Chief Milgram To Commit To Request Marijuana Review Timeline From HHS

Rep. Matt Gaetz (R-Fla.) and Rep. Steve Cohen (D-Tenn.) pushed the DEA chief on the agency's plans to remove marijuana from its status as a Schedule I drug on Thursday in a House Judiciary hearing on Thursday.